In a globalized and highly regulated market, speed and precision are key
Treeana Advisors accelerates the entry of your products into strategic markets across EMEA, LATAM, and APAC, combining a top-tier network of advisors with deep expertise in market access and commercial excellence.
Strategic
leadership in global healthcare consultancy
The Firm
Treeana
Born in 2025 from the vision of Antonio Roldan to support companies operating in pharmaceutical and surgical fields d using a long experience in health care industry.
The blueprint of global success for companies with breakthrough science that often have lacked the strategic guidance needed to bring their products to patients globally. It was in this environment that the firm came together. We spent decades inside the pharmaceutical ecosystem—across multinational companies, regulatory agencies, and market access organizations. We had seen firsthand how strong science could fail commercially, not because of inefficacy, but because of misaligned strategy when entering new markets.
We believed there was a gap. Not another consulting firm delivering generic frameworks, but a specialized advisory partner focused exclusively on international expansion in the pharmaceutical sector.
The firm was built on a simple idea:
Global expansion in pharma is not just a regulatory exercise—it is a strategic transformation.From day one, the firm positioned itself at the intersection of
• Commercial execution
• Local market insight
Rather than offering isolated services, the firm designed integrated pathways—helping pharmaceutical companies move succesfuly into global expansion
Focus
We are focused in partners with pharmaceutical and biotech companies at critical inflection points of their growth
• Entering new geographic markets
• Preparing for product launches across multiple regions
• Navigating complex regulatory landscapes
• Designing pricing and reimbursement strategies
• Building local partnerships and distribution networks
Each engagement is tailored, we do not believe in one-size-fits-all expansion models—because every molecule, market, and company ambition is different.
The approach is grounded in three principles:
Deep Market Understanding
Every recommendation is rooted in local realities—regulations, healthcare systems, payer behavior, and competitive dynamics.
End-to-End Thinking
From early clinical positioning to post-launch optimization.
Execution Focus
Strategy alone is not enough. The firm works alongside clients to implement decisions, bridging the gap between planning and real-world outcomes.
Advisors
Antonio Roldán
Founder & CEO / Executive advisor
As a senior executive with solid history of success in the pharmaceutical, medtech and life sciences industry I am a goal-driven and strategic sales experienced professional, recognized for transforming organizations, driving with international leadership multimillion-dollar growth, and building, leading, and empowering high-performing teams to exceed expectations. Expert negotiator establishing and managing solid relationships with strong ability to build and lead multicultural teams. Dynamic and analytical with a proven track record in leading turnaround and growth plans in the pharmaceutical and medtech industries with strong skills in business development, strategic leadership and corporate finance.
I am specialized in driving organizations through growth, transformation, and sustainable value creation, combining strategic foresight with commercial insight and a deep respect for people and culture with expertise in strategic governance and growth oversight, global commercial and P&L, digital and organizational transformation expertise and proven ability to align teams, goals, and performance. I believe in creating value by building trust, empowering leaders, and turning vision into measurable impact.
Walter Rodriguez
Executive advisor
I support organizations in strengthening business performance, enhancing operational effectiveness, and advancing their transformation toward sustainable growth.
I bring more than 25 years of experience in executive leadership roles within the ophthalmic pharmaceutical and medical device industries, with a track record across markets including LATAM and Spain. Throughout my career, I have contributed to performance improvement and business development in complex and dynamic environments.
In my role as an external consultant, I offer a strategic and structured perspective, complemented by a practical, results-oriented approach. My 360° view of the organization allows for the identification of critical areas and the development of effective, tailored solutions. I collaborate with management teams in transformation, realignment, and optimization initiatives, supporting the transition toward more focused, aligned, and performance-driven organizations.
My work is grounded in professionalism, integrity, and clear communication, with a strong emphasis on disciplined execution. The objective is to deliver measurable and sustainable outcomes, aligned with each organization’s strategic priorities.
Maria Grazia Mazzone
Executive advisor
I am a senior pharmaceutical executive and scientific leader with over 30 years of experience in end-to-end product development, industrial governance and strategic partnerships across ophthalmic pharmaceutical and medtech and having multidisciplinary R&D, QA, regulatory, Clinical and Operations Teams, ensuring scientific robustness, regulatory compliance, and industrial scalability for complex product portfolios.
My expertise covers formulation science, analytical development, drug delivery platforms, preclinical validation, clinical proof‑of‑concept, CMC documentation, GMP compliance, and technology transfer.
As Business Development & Open Innovation Executive Director, I structured and negotiated in‑licensing, out‑licensing, co‑development agreements, and strategic alliances with private companies, research institutes, and startups, overseeing portfolio governance. I also played a key role in the VITA Digital Health Accelerator, supporting early‑stage startups and strengthening Italy’s digital health ecosystem.
My track record includes successful collaborations with international players, patent filings, scientific publications, and leadership in European and national funded R&D programs. With a strong foundation in chemistry and decades of operational and scientific leadership, I bring technical reliability, regulatory rigor, and partnership‑oriented execution, supporting industrial partners in accelerating development, de‑risking innovation, and scaling high‑value therapeutic solutions.
Dr. Diyar Ajeel
Executive advisor
I am an experienced Ophthalmologist with more than 15 years of professional practice in ophthalmology.
I own and manage a private ophthalmic clinic and medical center, with extensive expertise in diagnosing and treating eye diseases. As a Key Opinion Leader (KOL) for several companies, I have strong experience in pharmaceutical products and medical devices, particularly intraocular lenses (IOLs).
My background combines clinical excellence with industry knowledge even supporting companies as an ophthalmologist and Key Opinion Leader (KOL) with a highly respected as clinician, surgeon and researcher who influences their peers, shapes clinical practice, and advises industry partners on new technology development often as speaker in podium presentations at international meetings, editorial board positions, and high-impact research publications.
Claudia Perrora
Lawyer & Master Legal Advisors / Managing Director
Dedicated International and Civil Law Attorney with a passion for navigating complex legal landscapes. I bridge the gap between different jurisdictions, providing smart, tailored solutions for both corporate and private clients. Whether it's cross-border disputes or intricate civil litigation, my approach is proactive, tech-savvy, and focused on delivering tangible results. Let’s turn legal challenges into strategic opportunities.
With over 20 years of experience navigating the complexities of International and Civil Law, I combine deep-rooted legal expertise with a modern, smart mindset.
In an increasingly interconnected world, I provide clients with the strategic foresight needed to handle cross-border regulations and intricate civil disputes with efficiency and precision. My approach is defined by clear communication, fast execution, and a perspective that looks three steps ahead.
Two decades of high-stakes litigation and international advisory have taught me that every challenge is an opportunity for a tailored, results-driven strategy.
Network
In a world where innovation knows no borders, we ensure that access doesn’t stop at them.
We operate as a trusted partner to pharmaceutical leaders navigating an increasingly complex global landscape in more than 70 countries across the globe in EMEA, LATAM, APAC and US.